Flebogamma® 5% DIF development: Rationale for a new option in intravenous immunoglobulin therapy: ORIGINAL ARTICLE

Clinical and Experimental Immunology

Volumn 157, Issue SUPPL. 1, 2009, Pages 17-21

  Jorquera, J I ^a  

^a Instituto Grifols   (Spain)

Author keywords

Flebogamma; Intravenous immunoglobulin; Nanofiltration; Pathogen safety

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; ANTIBODY TITER; CONFERENCE PAPER; CORYNEBACTERIUM DIPHTHERIAE; DRUG MANUFACTURE; DRUG PURITY; DRUG SAFETY; DRUG STABILITY; DRUG STORAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOTHERAPY; MEASLES VIRUS; NANOFILTRATION; NONHUMAN; PASTEURIZATION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INACTIVATION; VIRUS NEUTRALIZATION; ARTICLE; CHEMISTRY; DRUG CONTAMINATION; DRUG DEVELOPMENT; IMMUNOELECTROPHORESIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR WEIGHT; NANOTECHNOLOGY; SAFETY; STANDARD; ULTRAFILTRATION; VIRUS;

DRUG CONTAMINATION; DRUG DISCOVERY; DRUG STABILITY; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; MOLECULAR WEIGHT; NANOTECHNOLOGY; SAFETY MANAGEMENT; ULTRAFILTRATION; VIRUS INACTIVATION; VIRUSES;

EID: 67149102247     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03953.x     Document Type: Conference Paper

References (19)

1. Cohn EJ, Strong LE, Hughes WL et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946 68 : 459 75.
2. Cohn EJ, Gurd FRN, Surgenor DM, et al. A system for the separation of the components of human blood: quantitative procedures for the separation of the protein components of human plasma. J Amer Chem Society 1950 72 : 465 74.
3. Electrophoresis. European Pharmacopoeia: 2.2.31.
4. Immunochemical methods. European Pharmacopoeia: 2.7.1.
5. Liquid chromatography. European Pharmacopoeia: 2.2.29.
6. Bradford M. Anal Biochem 1976 72 : 248.
7. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Test for Fc function of immunoglobulin. European Pharmacopoeia: 2.7.9.
8. Test of anticomplementary activity of immunoglobulin. European Pharmacopoeia: 2.6.17.
9. Prekallikrein activator. European Pharmacopoeia: 2.6.15.
10. Anti-A and anti-B haemagglutinins (indirect method). European Pharmacopoeia: 2.6.20.
11. Anti-D antibodies. European Pharmacopoeia: 2.6.26.
12. Lennette E, Schmidt NJ. Diagnostic procedures for viral, rickettsial and chlamydial infections, 5th edn. Washington, DC : American Public Health Association, 1979.
13. Rose NE, Hamilton RG, Detrick B (Eds). Manual of clinical laboratory immunology. Washington DC, American Society for Microbiology Press. 1997. p. 690.
14. Dumas J, Bordet P, Laporte R, Pichon J, Prevot AR. Bacteriologíe medicale. Paris : Ed Medicales Flammarion, 1951.
15. Revised CPMP Guideline in Virus validation studies. CPMP/BWP/268/95. 1995.
16. Note for guidance on plasma-derived medicinal products. CPMP/BWP/269/95. 1995.
17. Quality of biotechnological products viral safety evaluation by biotechnology products derived from cell lines of human or animal origin. CPMP/ICH/295/95. 1995.
18. Yap PL. Aplicaciones clínicas del tratamiento con inmunoglobulinas intravenosas, Barcelona. JR Prous, 1993.
19. Vlug A, Nieuwenhuys EJ, van Eijk RV, Geertzen HG, van Houte AJ. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin 1994 52 : 561 7.